Covid-19: A “bivalent” vaccine has just been approved in the UK

The regulator medicines (the MHRA for Medicines and Healthcare Products Regulatory Agency) announced last Monday to approve an updated version of the vaccine against the Covid-19made by Modern. The booster vaccine called “bivalent” half targets the original strain of the virus of 2020 and half of the variant Omicron. A communication from the MHRA indicates that it causes ” a strong immune response “, as well as'” a good immune response against Omicron BA.4 and BA.5 sub-variants ».

« What this bivalent vaccine gives us is a sharper tool in our toolbox to help protect us against this disease as the virus continues to evolve. said Dr June Raine, Chief Executive of the MHRA. The agency says no serious safety issues were noted and the side effects observed were similar to those seen for the original Moderna booster dose.

The United Kingdom thus becomes the first country in the world to approve a bivalent vaccine that targets Omicronvariant now most common in Europe.

See also  El Confidencial (Spain): Mineral That Really Helps Prevent Colds and Help You Heal Faster, New Research Finds | Society | Inosmi



Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Social Media

Most Popular

On Key

Related Posts